Farms.com Home   News

AgriRecovery Payments Flowing

Most recent numbers from the office of Manitoba Agriculture Minister Ralph Eichler show the government has approved $1.67 million from 118 claims for drought assistance through AgriRecovery.

Carson Callum is general manager of Manitoba Beef Producers.

"It's good to see that payments have been moving and producers have been able to get applications approved and cheques sent out the door. I think that's pretty good for an AgriRecovery initiative, when you consider the provincial and federal negotiations that need to go into it," he commented. "But we still understand that the current details of AgriRecovery still need to be looked at and how they could potentially be adjusted to include a bit of eligibility for some of the extraordinary costs that producers incurred as a result of the drought. Conversations that we're still having with the department to see what adjustments can be made."

The province notes it remains committed to processing applications as quickly as possible and payments continue to be processed on an ongoing basis.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.